How do immune cells strike a balance, unleashing rapid attacks against pathogens or cancer, while avoiding damage to healthy cells? Research into an immune kill switch holds potential for controlling ...

Cancer cells have softer membranes than healthy cells. New nanoparticles exploit this physical difference to fuse selectively ...

Investigators studied expression of type I interferons, key pathogenic drivers in systemic lupus erythematosus and lupus nephritis.

Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.

A vitamin A byproduct could weaken the immune system's cancer-fighting ability, according to new Princeton University ...

The very high death toll amongst pigs infected with African Swine Fever virus (ASFv) in pigs could be very well related to ...

Preclinical in vivo efficacy data in atopic dermatitis extend previous PoC in allergic asthmaPositive opinion from the European Patent Office strengthens patent protection of ATP-R13Progress ...

Scientists have uncovered a troubling role for a vitamin A byproduct in cancer, which appears to help tumours slip past the ...

The detailed mapping revealed an unexpected pattern. One specific section of the dendrite contained an unusually dense ...

Durable complete responses with CAR-NK + Rituximab in patients who failed current standards of care in Waldenstrom’s ...

A vitamin A byproduct has been found to quietly disarm the immune system, allowing tumors to evade attack and weakening ...